O
AGN

OppenheimerFunds’s Allergan plc AGN Stock Holding History

OppenheimerFunds’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$48.1M Sell
328,855
-19,194
-6% -$2.78M 0.06% 319
2018
Q4 		$46.5M Sell
348,049
-130,689
-27% -$21.4M 0.07% 287
2018
Q3 		$91.2M Sell
478,738
-1,451
-0.3% -$267K 0.11% 215
2018
Q2 		$80.1M Sell
480,189
-11,992
-2% -$1.93M 0.1% 233
2018
Q1 		$82.8M Sell
492,181
-5,046
-1% -$846K 0.1% 219
2017
Q4 		$81.3M Sell
497,227
-34,871
-7% -$6.26M 0.1% 217
2017
Q3 		$109M Sell
532,098
-59,634
-10% -$13.9M 0.13% 175
2017
Q2 		$144M Sell
591,732
-173,612
-23% -$40.8M 0.18% 145
2017
Q1 		$183M Buy
765,344
+6,604
+0.9% +$1.54M 0.22% 124
2016
Q4 		$159M Sell
758,740
-567,701
-43% -$118M 0.2% 130
2016
Q3 		$305M Sell
1,326,441
-210,984
-14% -$51.6M 0.38% 65
2016
Q2 		$355M Sell
1,537,425
-240,055
-14% -$55.3M 0.47% 51
2016
Q1 		$476M Sell
1,777,480
-54,578
-3% -$15.6M 0.63% 27
2015
Q4 		$573M Sell
1,832,058
-565,873
-24% -$168M 0.73% 21
2015
Q3 		$652M Sell
2,397,931
-336,755
-12% -$103M 0.88% 13
2015
Q2 		$830M Sell
2,734,686
-383,476
-12% -$114M 0.95% 15
2015
Q1 		$928M Buy
3,118,162
+87,939
+3% +$25.1M 1.04% 6
2014
Q4 		$780M Buy
3,030,223
+337,920
+13% +$84.5M 0.87% 11
2014
Q3 		$650M Sell
2,692,303
-416,556
-13% -$93.2M 0.71% 24
2014
Q2 		$693M Buy
3,108,859
+246,715
+9% +$51.1M 0.77% 17
2014
Q1 		$589M Buy
2,862,144
+223,209
+8% +$44.2M 0.7% 23
2013
Q4 		$443M Buy
2,638,935
+2,353,335
+824% +$368M 0.54% 40
2013
Q3 		$41.1M Sell
285,600
-3,159,150
-92% -$421M 0.03% 530
2013
Q2 		$435M Buy
+3,444,750
New +$390M 0.63% 27

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

OppenheimerFunds's AGN Position: Q1 2019 in Review

OppenheimerFunds reduced its Allergan plc (AGN) stake by 5.5% in Q1 2019, selling an estimated $2.78M and leaving 328,855 shares worth $48.1M. The position accounts for 0.06% of the portfolio, ranked #319.

OppenheimerFunds first reported a position in AGN in Q2 2013 and has held it in 24 quarters since. The position peaked at $928M in Q1 2015. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • OppenheimerFunds held 328,855 shares of Allergan plc worth $48.1M as of Q1 2019.
  • OppenheimerFunds sold 19,194 Allergan plc shares in Q1 2019, an estimated $2.78M.
  • Allergan plc made up 0.06% of OppenheimerFunds's portfolio in Q1 2019, its #319 holding.
  • OppenheimerFunds first reported a position in Allergan plc in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Allergan plc position peaked at $928M in Q1 2015.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.